Company Website: http://www.bms.com
PRINCETON, N.J. -- (Business Wire)

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of fifty-seven cents ($0.57) per share on the $0.10 par value common stock of the company. The dividend is payable on November 1, 2023, to stockholders of record at the close of business on October 6, 2023.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on December 1, 2023, to stockholders of record at the close of business on October 31, 2023.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20230920964458/en/

Contacts:

For more information:

Media:
media@bms.com

Investors:
investor.relations@bms.com

Source: Bristol Myers Squibb